Compare Stryker Corporation (SYK) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Stryker Corporation vs GeneDx Holdings Corp — how do they compare? Stryker Corporation trades at $319.04 (market cap $122.35B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: Stryker Corporation is far larger — about 68× GeneDx Holdings Corp's market cap, and Stryker Corporation pays a 1% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| SYK | WGS | |
|---|---|---|
Market Cap | $122.35B | $1.80B |
Sector | Technology | Technology |
52-Week High | $403.53 | $167.51 |
52-Week Low | $282.58 | $34.51 |
Enterprise Value | $134.10B | $1.80B |
Dividend Yield | 1% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
